Masakatsu Motomura Selected Research

myasthenia gravis anti-skeletal muscle antibody (ASMA)

5/2018	Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
1/2015	Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
1/2013	[A case of thymoma-associated myasthenia gravis with anti-MuSK antibodies].
10/2012	Childhood-onset anti-MuSK antibody positive myasthenia gravis demonstrates a distinct clinical course.
3/2011	[A pregnant patient with anti-MuSK antibody positive myasthenia gravis and her infant with transient neonatal myasthenia gravis].
7/2009	[Anti-MuSK antibody-positive myasthenia gravis with nephrotic syndrome: a case report].
7/2005	[A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
6/2005	Myasthenia gravis with anti-MuSK antibody, showing progressive muscular atrophy without blepharoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masakatsu Motomura Research Topics

Disease

34	Myasthenia Gravis 12/2019 - 01/2003
7	Neoplasms (Cancer) 06/2018 - 09/2003
7	Thymoma (Thymic Carcinoma) 01/2014 - 05/2007
6	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 04/2022 - 01/2003
5	Muscle Weakness 05/2018 - 09/2006
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2015 - 09/2005
3	Neurologic Manifestations (Neurological Manifestations) 02/2019 - 07/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 02/2011
3	Disease Progression 10/2012 - 01/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2022 - 06/2018
2	Cerebellar Ataxia (Dysmetria) 02/2019 - 05/2008
2	Paraneoplastic Cerebellar Degeneration 01/2019 - 01/2003
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2019 - 07/2011
2	Vision Disorders (Hemeralopia) 06/2018 - 04/2015
2	Thymus Hyperplasia 01/2018 - 01/2014
2	Lymphadenopathy 01/2016 - 12/2011
2	Optic Neuritis (Retrobulbar Neuritis) 01/2016 - 04/2015
2	Infections 04/2015 - 01/2012
2	Muscular Diseases (Myopathy) 01/2015 - 11/2003
2	Polymyositis 01/2015 - 09/2005
2	Leukocytosis (Pleocytosis) 01/2013 - 01/2013
2	Encephalitis (Encephalitis, Rasmussen) 01/2012 - 11/2010
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 07/2011 - 06/2008
2	Dermatomyositis (Dermatopolymyositis) 01/2011 - 09/2005
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2007 - 01/2007
1	Neuromyelitis Optica (Devic's Disease) 01/2019
1	Deglutition Disorders (Dysphagia) 05/2018
1	Neuroendocrine Carcinoma 02/2018
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2018
1	Immunoglobulin G4-Related Disease 01/2016
1	Multiple Sclerosis 01/2016
1	Pain (Aches) 04/2015
1	Central Nervous System Lupus Vasculitis 04/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Neuromuscular Diseases (Neuromuscular Disease) 09/2014
1	Edema (Dropsy) 01/2014
1	Arthritis (Polyarthritis) 01/2014
1	Rheumatoid Arthritis 01/2014
1	Macrophage Activation Syndrome 04/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2013
1	Hypothyroidism 01/2013
1	Pulmonary Sarcoidosis 01/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2013
1	Graves Disease (Basedow Disease) 01/2013
1	Aseptic Meningitis 01/2012

Drug/Important Bio-Agent (IBA)

19	AntibodiesIBA 02/2019 - 02/2005
18	AutoantibodiesIBA 02/2019 - 10/2009
15	muskIBA 05/2018 - 02/2005
14	Cholinergic ReceptorsIBA 03/2014 - 01/2003
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2005
8	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 05/2018 - 06/2005
6	SteroidsIBA 04/2015 - 03/2002
6	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2014 - 08/2011
5	Calcium Channels (Calcium Channel)IBA 04/2022 - 01/2003
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2018 - 02/2005
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2015 - 05/2007
4	Immunoglobulin G (IgG)IBA 01/2019 - 07/2009
4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018 - 09/2012
4	Prednisolone (Predate)FDA LinkGeneric 01/2018 - 12/2011
3	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 02/2019 - 01/2003
3	Phosphotransferases (Kinase)IBA 09/2014 - 07/2009
3	LDL Receptors (LDL Receptor)IBA 05/2013 - 02/2011
3	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2013 - 11/2009
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2012 - 11/2009
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016 - 04/2015
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015 - 08/2002
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 11/2011 - 02/2011
2	AcetylcholinesteraseIBA 07/2011 - 09/2006
2	AntigensIBA 04/2010 - 09/2005
2	Complement System Proteins (Complement)IBA 04/2010 - 01/2003
2	tau Proteins (tau Protein)IBA 01/2007 - 01/2007
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2022
1	margatoxinIBA 09/2019
1	Claudin-5IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2019
1	Semaphorin-3AIBA 06/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2015
1	CytokinesIBA 04/2015
1	Amino Acids FDA Link 01/2015
1	GlucocorticoidsIBA 01/2015
1	Branched-Chain Amino AcidsIBA 01/2015
1	Muscle Proteins (Muscle Protein)IBA 09/2014
1	Anti-Citrullinated Protein AntibodiesIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Indicators and Reagents (Reagents)IBA 09/2012
1	MacrolidesIBA 09/2012
1	Immunologic Factors (Immunomodulators)IBA 09/2012
1	anti-ryanodine receptor autoantibodyIBA 06/2012
1	Dacarbazine (DIC)FDA LinkGeneric 01/2012

Therapy/Procedure

10	Therapeutics 05/2018 - 03/2002
4	Thymectomy 12/2019 - 06/2008
3	Activities of Daily Living (ADL) 04/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 04/2022 - 09/2003
2	Bite Force (Occlusal Forces) 09/2012 - 07/2010
2	Plasma Exchange 07/2005 - 08/2002
1	Thyroidectomy 01/2013